Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
41. lappuse
... immediately . ( 2 ) ( i ) The warning statement required by paragraph ( c ) ( 1 ) of this section shall appear ... immediate container is not the retail package , the warning statement required by paragraph ( c ) ( 1 ) of this ...
... immediately . ( 2 ) ( i ) The warning statement required by paragraph ( c ) ( 1 ) of this section shall appear ... immediate container is not the retail package , the warning statement required by paragraph ( c ) ( 1 ) of this ...
63. lappuse
... immediate di- rection the drug is administered or dis- pensed to a subject ) . In the event an in- vestigation is conducted by a team of individuals , the investigator is the re- sponsible leader of the team . " Sub- investigator ...
... immediate di- rection the drug is administered or dis- pensed to a subject ) . In the event an in- vestigation is conducted by a team of individuals , the investigator is the re- sponsible leader of the team . " Sub- investigator ...
206. lappuse
... immediate container label and that are not mar- keted in another retail package ( e.g. , an outer box ) , the statement of the per- centage of alcohol present in the prod- uct shall appear prominently and con- spicuously on the ...
... immediate container label and that are not mar- keted in another retail package ( e.g. , an outer box ) , the statement of the per- centage of alcohol present in the prod- uct shall appear prominently and con- spicuously on the ...
302. lappuse
... immediate containers of each po- tency of insulin injection shall be dis- tinguished by the following colors : Red , if it contains 40 U.S.P. Units of insu- lin per milliliter . White , if it contains 100 U.S.P. Units of in- sulin per ...
... immediate containers of each po- tency of insulin injection shall be dis- tinguished by the following colors : Red , if it contains 40 U.S.P. Units of insu- lin per milliliter . White , if it contains 100 U.S.P. Units of in- sulin per ...
308. lappuse
... immediate container therein or the seal of the immediate container is broken , or when its label or labeling ceases to conform to any requirement of § 429.11 or § 429.12 . ( 3 ) With respect to any package , when the drug therein so ...
... immediate container therein or the seal of the immediate container is broken , or when its label or labeling ceases to conform to any requirement of § 429.11 or § 429.12 . ( 3 ) With respect to any package , when the drug therein so ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning